Aqtion platform offers investors a gateway to investment opportunities in pre-vetted early-stage startups and also a secondary investment.
B2B2C
Series A
U.S.
$ 10,000,000
VCs, Private Investor
4.7
2015
Developed technology
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Convergence of trusted Computing's investment in endpoint security with the explosive opportunity in blockchain's anonymous transactions.
Ref 18
Sector:
Cybersecurity Blockchain Internet Hardware
B2B
Seed
France
€ 1,000,000
VCs, Private Investor
4.5
2018
4M€ in sales in 4Q2019
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
The only user friendly AI based medical imaging platform. Cledo is offering a ready to use solution to help Practitioners create AI tools applied to imaging.
Cledo
Sector:
Healthcare AI
B2B
Seed
Italy
€ 1,500,000
VCs, Private Investor
3.8
2012
Services
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Integration the pathology detection based on AI, image recognition models to existing projects. BEP in revenue is in 2019. Target turnover in 2022- 10 M€
Patho
Sector:
Healthcare AI
B2B, B2C, B2B2C
Series A
Israel
$ 3,000,000
VCs, Private Investor
4.0
2017
Beta
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Dealing with lost of cognitive power by elderly people. Category: VR, medical devices, digital healthcare
GetB
Sector:
Digital health
B2C, B2B2C
Seed
Switzerland
€ 100,000,000
Institutional investor
4.5
2018
MVP, asset connected
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Disruptive platform for future medical treatment
Aevolve
Sector:
Blockchain +biotech
B2B2C
Seed
France
€ 1,000,000
VCs, Private Investor
4.3
2019
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Blockchain empowered platform for precision of medical diagnosis
Medo
Sector:
Digital health + Blockchain
B2C
Series C
the U.S.
€ 30,000,000
Private Investor
5.0
2011
FDA approved
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
The FDA approved treatment that can be used for diseases for Alzheimer’s and diabetics .
Alab
Sector:
Medtech
B2B2C, B2B
Seed
France
€ 1,500,000
VCs, Private Investor
4.0
2018
Beta
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Digital Platform for to evaluate the risk associated with major common pathologies. Categories: e-Health, Woman Health, Healthcare.
Ely
Sector:
Digital Health
Developed drug
IP
France
€ 30,000,000
VCs to Pharma
4.8
2014
Developed
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Patented technology of one of the major important mineral supplements. Clinically proven. Superior technology in terms of dosage, bioavailability, absorption, cost, efficiency.
Dev_drug
Sector:
Biotech
B2C, B2B2C
Seed
Switzerland
€ 3,000,000
VCs, Private Investor
3.8
2019
Buz plan, partnerships
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Predictive medicine: cells , DNA
DLife
Sector:
Healthcare + hospital
B2B
Seed
Italy
€ 1,000,000
VCs, Private Investor
4.2
2010
Pre-clinical package
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Senolytics: selectively kill senescent cells
BioxVSR
Sector:
Biotech
B2B
Series A
Israel
€ 7,000,000
VCs, Private Investor
4.0
2016
Critical mass users, POC
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Global Online Physicians Community Connecting the industry to physicians and connecting physicians to physicians (TRUSTED P2P)
GM
Sector:
Digital health
B2B
Series A
France
€ 4,000,000
VCs, Private Investor
4.8
2015
Revenue generated
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Proprietary Technology. Quantitative Analysis for pre-clinical models. Permit conduct comparative studies between different labs. Currently specialized on 2 diseases.Categories: AI,ML, Healthcare.
Bcel
Sector:
Healthcare
B2B
Series C
UK
€ 1,500,000
Private Investor
4.2
2009
Stage 3 clinical trials
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
Cellular medicines, Stage 3 clinical trials
Cel
Sector:
Biotech